Samsung Biologics Profit Improves Yet Stock Undervalued: Why Samsung Biologics is rated Buy as strong margins and revenue growth persist despite labor disruption fears, leaving the stock below the average analyst target. 2026년 07월 07일 English
E-Mart Shares Priced for Pessimism: 8.2x Value Case E-Mart stock is rated Buy with low valuation (PER 8.2); sentiment fears from a Starbucks controversy drive declines, while results show improving gross profit and shrinking operating losses, but durable operating profit is still needed. 2026년 05월 20일 English
